← Back to Search

Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis/Injury (SAD Trial)

N/A
Waitlist Available
Led By Andrew W Kirkpatrick, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patients will be followed-up for 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is evaluating the effectiveness of actively removing peritoneal fluid through a commercial suction device compared to passive drainage of the same fluid drained through standard surgical drains.

Eligible Conditions
  • Abdominal compartment syndrome
  • Abdominal Compartment Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patients will be followed-up for 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and patients will be followed-up for 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Systemic inflammatory marker levels and peritoneal fluid inflammatory marker levels
Secondary study objectives
Global Outcomes
Physiological Outcomes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: KCI AbTheraExperimental Treatment1 Intervention
commercial AbThera vacuum assisted abdominal closure at 125 mmHg suction
Group II: "Stampede" VACActive Control1 Intervention
Calgary-home-made "Stampede" VAC system with only closed drain bulb suction
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
KCI AbThera
2011
N/A
~50

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
811 Previous Clinical Trials
892,765 Total Patients Enrolled
3MIndustry Sponsor
159 Previous Clinical Trials
31,526 Total Patients Enrolled
Alberta Health servicesOTHER
163 Previous Clinical Trials
652,608 Total Patients Enrolled
Andrew W Kirkpatrick, MDPrincipal InvestigatorCanadian Trauma Trials Collaborative
2 Previous Clinical Trials
695 Total Patients Enrolled
~3 spots leftby Dec 2025